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Background: The accuracy of dose calculation is crucial to the quality of treatment planning and, consequently, to the
dose delivered to patients undergoing radiation therapy. Current general calculation algorithms such as Pencil Beam
Convolution (PBC) and Collapsed Cone Convolution (CCC) have shortcomings in regard to severe inhomogeneities,
particularly in those regions where charged particle equilibrium does not hold. The aim of this study was to evaluate
the accuracy of the PBC and CCC algorithms in lung cancer radiotherapy using Monte Carlo (MC) technology.
Methods and materials: Four treatment plans were designed using Oncentra Masterplan TPS for each patient.
Two intensity-modulated radiation therapy (IMRT) plans were developed using the PBC and CCC algorithms, and
two three-dimensional conformal therapy (3DCRT) plans were developed using the PBC and CCC algorithms. The
DICOM-RT files of the treatment plans were exported to the Monte Carlo system to recalculate. The dose
distributions of GTV, PTV and ipsilateral lung calculated by the TPS and MC were compared.
Result: For 3DCRT and IMRT plans, the mean dose differences for GTV between the CCC and MC increased with
decreasing of the GTV volume. For IMRT, the mean dose differences were found to be higher than that of 3DCRT.
The CCC algorithm overestimated the GTV mean dose by approximately 3% for IMRT. For 3DCRT plans, when the
volume of the GTV was greater than 100 cm3, the mean doses calculated by CCC and MC almost have no difference.
PBC shows large deviations from the MC algorithm. For the dose to the ipsilateral lung, the CCC algorithm
overestimated the dose to the entire lung, and the PBC algorithm overestimated V20 but underestimated V5; the
difference in V10 was not statistically significant.
Conclusions: PBC substantially overestimates the dose to the tumour, but the CCC is similar to the MC simulation.
It is recommended that the treatment plans for lung cancer be developed using an advanced dose calculation
algorithm other than PBC. MC can accurately calculate the dose distribution in lung cancer and can provide a
notably effective tool for benchmarking the performance of other dose calculation algorithms within patients.
Keywords: 3-Dimensional conformal radiation therapy, Collapsed cone convolution, Pencil beam convolution,
Lung cancer, Monte Carlo, Intensity-modulated radiation therapyIntroduction
The accuracy of dose calculation is crucial to the quality
of treatment planning and, consequently, to the dose
delivered to patients undergoing radiation therapy [1].
In the past 20 years, radiotherapy has become increas-
ingly complex. Complex treatments such as intensity-
modulated radiation therapy (IMRT) are expected to
provide better treatment outcomes for patients and better* Correspondence: dengwangpei@163.com
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unless otherwise stated.sparing of healthy tissues [2]. The increased complexity of
the delivery and dosimetry of radiotherapy treatments
arising from the increasing use of IMRT treatments has
led to an increased demand for accurate treatment veri-
fication [2]. The International Commission on Radiation
Units and Measurements (ICRU) recommends that
patient-specific independent treatment plan verification
should be performed for all IMRT treatments [3].
There is general agreement that, in IMRT, the actual de-
livered dose (or location) should be within 3% (or 3 mm)
of the planned TPS [4]. But what is the actual dose? Weis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tation of the calculated plan. Patient-specific pre-treatment
quality assurance can be performed using film, ion cham-
ber and diode arrays. But most of Patient-specific QA were
performed on phantom, which will lead to a lack of pre-
dictive power for ? clinically relevant patient dose errors.?
[5] The ICRU Report 83 recommends that as an alterna-
tive to a set of measured absorbed-dose distributions, it is
acceptable to use independent absorbed-dose calculations
instead of performing measurements. Currently, inde-
pendent absorbed-dose calculations have been performed
in many radiotherapy centres, but some of them use sim-
ple correction-based dose verification calculations, which
are known to be less accurate than the treatment planning
algorithms that they are designed to verify [6]. The use of
inferior standards for QA procedures might lead to high
false-negative or false-positive rates. Therefore, the accuracy
of the independent absorbed-dose calculation which was
used to evaluate the IMRT algorithm should be equivalent
or higher than that of the treatment-planning system. A
Monte Carlo algorithm would be acceptable for determin-
ing the absorbed dose in the presence of inhomogeneous
tissue if the Monte Carlo code is tested sufficiently [3].
In routine clinical applications, calculations of dose to
the tumour are performed by commercial treatment
planning systems (TPS). The majority of these systems
employ a Pencil Beam Convolution (PBC) algorithm for
dose calculation. This algorithm is commonly used in
clinical practice because it is very fast, but it is widely
known that PBC has shortcomings in regard to severe
inhomogeneities, particularly in those regions where
charged particle equilibrium does not hold. This is es-
pecially questionable for target dose calculations in
lung cancer treatments. In some previous studies, the
prediction of PBC deviates from the measured values by
as much as 15% [7,8]. Another algorithm, the Collapsed
Cone Convolution (CCC), is utilised in commercial
treatment planning systems, and the CCC algorithm
produces values that are closer to the measured values
than the PBC algorithm [9,10] but still deviates from
the measurement by more than 5% under certain cir-
cumstances [7,8,11-13].
Monte Carlo (MC) simulation has proved to be the
most accurate dose calculation and is therefore used to
evaluate other dose calculation algorithms [7,8,11-16].
The MC method is potentially highly accurate as it can
faithfully model both photon scatter and electron trans-
port in arbitrary materials. Although benchmarking of
commercial TPS dose calculations should ideally be per-
formed against measured dose distributions, situations
can occur where measurement cannot be made with
high accuracy; in such situations, the MC algorithm is
used as a reference against which TPS calculations can
be benchmarked [17].Although comparisons of MC calculation with the
model-based calculations were reported elsewhere [12,13],
great majority of previous studies have been performed
for a phantom study or a specific site, and to our know-
ledge few studies has been devoted to intensity modulated
radiation (IMRT) for clinical lung cancer. In this study,
we will compare the dose distributions for 24 lung can-
cer patients, including the dose distributions calculated
by MC, CCC and PBC for 3DCRT and IMRT.
Materials and methods
Patients and treatment planning
A total of 24 lung cancer patients, who had been previ-
ously treated at our hospital, were randomly selected for
this study. The tumour size and location varied from pa-
tient to patient. The treatment plans were based on the
patient CT scanned in a supine position under normal
free breathing conditions. Mean grass tumour volume
(GTV) size was 68.9 ? 56 cm 3 (range, 5 ~ 162 cm3) and
mean planning target volume (PTV) size was 133.9 ?
99.2 cm3 (range, 21 ~ 305.7 cm3). The Oncentra Master-
plan V4.1 treatment planning system was used for the
plan dose calculation. The Oncentra Masterplan TPS
employs two algorithms, the Pencil Beam Convolution
(PBC) and the Collapsed Cone Convolution (CCC).
Four plans were designed for each patient, two 3DCRT
plans, one that used the CCC and one that used the
PBC, and two IMRT plans, one of which that used the
CCC and one that used the PBC for plan optimizations
and final dose calculations, respectively. To facilitate the
comparison, the parameters of the two IMRT plans were
the same, and the conditions of the two 3DCRT plans
were identical. The calculation grid size was 0.3 cm ?
0.3 cm ? 0.3 cm for all plans. For IMRT plans, the mini-
mum open field size was 4 cm2 and minimum MU per
segment was 3 MU, and the delivery type was step-and-
shoot. For all of the plans, the prescribed dose was 60 Gy/
30Fx, and all plans were normalized so that 95% of PTV
received ≥100% prescribed dose. Radiation treatments
were delivered on an 8 MV Varian 23 EX linear acceler-
ator equipped with a multileaf collimator (60 pairs, the
minimum leaf width projection into the iso-centre Plane
is 5 mm). The patient? s CT and the patient? s RTPLAN files
were exported to the MC work station to recalculate the
dose distribution.
Monte Carlo calculation
This study was performed using BEAMnrc [18], DOS-
XYZnrc [19] and a well-commissioned in-house Monte
Carlo code MCSIM [20] which came from the Fox Chase
Cancer Center. MCSIM is a system based on EGS4, which
accepts standard DICOM-RT files exported from a com-
mercial treatment planning system and produces MC
calculated dose distributions.
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23EX linear accelerator 8 MV photon beam employed in
this investigation has been thoroughly tested. In this
model, the phase-space source that has been fine-tuned
was used to reproduce dose profiles and percent depth
doses (PDD) in water phantom. The dose profiles curves
and percent depth doses curves from Monte Carlo calcula-
tion were compared to the measurements, and they were in
good agreement with measurements.
The accuracy of phase-space source also tested and veri-
fied in a solid water phantom. A solid water phantom with
a virtual tumor was employed in our study, and a seven-
field (10 ? 10 cm 2 open fields) 3DCRT treatment plan was
created by TPS for a tumor which diameter was 8 cm.
The plan was calculated using CCC and was imported in a
DICOM-RT format from TPS to the MC system to recal-
culate. Dose distributions and cumulative dose-volume
histograms (DVHs) in the water-equivalent phantom cal-
culated by CCC and MC are shown in Figure 1. From the
figure we know that the dose distributions calculated by
CCC and MC agreed very well. In the same way, four
3DCRT treatment plans which field sizes were 5 ? 5, 15 ?
15, 20 ? 20, 25 ? 25 cm 2, respectively, for corresponding
virtual tumor which diameter were 3, 12, 18 and 22 cm
were all recalculated using MC and compared with corre-
sponding TPS calculations, the discrepancies in the corre-
sponding target dose were within 1%.
In this study, the Monte Carlo calculation grid size was
0.2 cm ? 0.2 cm ? 0.3 cm, the ECUT= 0.7 MeV, PCUT=
0.01 MeV. In all patient calculations, we have kept the stat-
istical uncertainty to be 2% or less so as not to significantly
affect isodose lines, DVHs, or biological indices [21].Figure 1 Comparison of dose distributions and DVHs calculated using
phantom. On the left are the dose distributions, thick line represents MC a
represents TPS and dotted line represents MC.The absolute dose was calculated by converting the
MC calculated dose per fluence to the dose per MU
under linac calibration conditions in water (depth of
2 cm, 10 ? 10 cm 2 field size, 100 cm SSD, and 100 cGy
for 100 MU).
Lung phantom dose measurement
The QUASAR multi-purpose body phantom was employed
to model a patient thorax: it is a 30 cm wide, 12 cm long
and 20 cm high acrylic body oval; with openings for cylin-
drical inserts of 8 cm and 2 cm diameter. These openings
allow the placement of ion chambers for measurement.
Two 8 cm diameter cedar wood cylindrical inserts were
placed into the openings, approximately representing
lung tissue, and one 2 cm diameter tumour-equivalent
rod was inserted with the points of measurement. The
phantom is shown in Figure 2. In the QUASAR multi-
purpose body phantom, two 3DCRT plans with 5 fields
were designed for the 2 cm diameter tumour using the
Oncentra Masterplan treatment planning system. One
plan was calculated using PBC and the other was calcu-
lated using CCC, the plan prescribed dose for 95%
volume of tumour were 200 cGy. The treatment plan? s
DICOM-RT files were imported into the MC system to
recalculate, and the two treatment plans were also delivered
on linac. An IBA CC13 ion chamber was used for dose
measurement.
Statistical analysis
The percent difference between the TPS algorithms and
the MC simulations were compared for all plan evalu-
ation parameters. Pairwise comparisons were performedCCC and MC for a 8 cm diameter virtual tumor in solid water
nd thin line represents TPS, On the right are the DVHs, solid line
Figure 2 QUASAR lung phantom with ion chamber in the
tumor insert.
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cant. A linear regression model was used to test correl-
ation between the percent differences in plan evaluation
parameters. R2 values were used to evaluate goodness of
fit of the linear models.
Results
Lung phantom dose measurement
In the QUASAR multi-purpose body phantom, the dose
to the tumour centre was compared among all the cal-
culations and measurements. The results of the TPS
calculations, the MC calculations and the ion chamber
measurements are listed in Table 1. The table reveals
that the MC calculation doses are very close to the
measurements, and the discrepancies between the MC
calculations and the measurements are within 1%.
Clinical study
Dose distributions and plan evaluation parameters calcu-
lated with the MC algorithm were compared to the PBC
and CCC algorithms. The PBC and CCC result minus the
MC result was expressed as a percentage. Dose-volume
histograms (DVHs) were created for each patient. The
GTV, PTV and ipsilateral lung were compared. Due to
their clinical utility for predicting OAR toxicity, the dose-
volume points were used for comparison. For lung, the
dose-volume points V5, V10, and V20 (the lung volume that
receives at least 5, 10 and 20 Gy, respectively) were used.
To evaluate the differences in the stability of the dose-Table 1 Results of dose comparison for the tumour centre am
measurements
CCC algorithm evaluation
Meas CCC MUs DiffCCC-Meas MC DiffMC-Meas
203.1 199.6 250 −1.7% 202.6 0.2%
Note: CCC = Collapsed Cone Convolution; PBC = Pencil Beam Convolution; MC =Movolume points that denote target coverage, the dose vol-
ume points near-minimal dose (D98), D95, D90, D50, near-
maximum dose (D2) (dose received by 98, 95, 90, 50, and
2% of the volume, respectively) were compared.
Figure 3 shows the comparisons of dose distributions
and DVHs of a lung cancer patient? s four treatment plans.
The dose distributions are on the left and the DVHs are
on the right. In general, CCC calculations are closer to
MC calculations for this patient; the PBC calculations ex-
hibit large deviations from the MC calculations.
Table 2 and Table 3 show the results of the statistical
analysis of GTV, PTV and ipsilateral lung for all 24 pa-
tients, and the corresponding P values are listed in the
table.
Figure 4a shows the mean dose differences of GTV be-
tween CCC and MC. For 3DCRT, the mean dose differ-
ences for the GTV decreases with increasing of the
GTV volume; when the volume of the GTV was greater
than 100 cm3, the mean doses calculated by CCC and
MC almost have no difference. For the IMRT plans, the
mean dose differences were larger than that of the
3DCRT plans. As shown in Table 2, the mean dose dif-
ference (CCC vs. MC) in the GTV for IMRT is 3.43%
and 3.05% for the PTV. The mean dose difference (CCC
vs. MC) in the GTV for 3DCRT is 0.62% and 0.42% for
the PTV. P > 0.05 indicates that the difference between
the CCC and MC for the 3DCRT plans is not statisti-
cally significant.
PBC shows large deviations from MC. Figure 4b
shows that the mean dose differences for GTV be-
tween the PBC and MC increases with decreasing
GTV volume for both 3DCRT and IMRT. PBC over-
estimated the mean dose of GTV and PTV, and
when the volume of GTV was less than 10 cm3, the
difference increases substantially, the maximum
difference in the mean dose for individual patients
was as high as 19%. As shown in Table 2, the mean
dose difference (PBC vs. MC) in the GTV for 3DCRT
plans was 5.95% and 7.96% for the PTV, and the mean
dose difference (PBC vs. MC) in the GTV for IMRT plans
is 7.81% and 10.23% for the PTV.
From Table 2 we know that the difference of D98 be-
tween CCC and MC is the largest among all dose-volume
points in IMRT, and the difference become smaller grad-
ually from D98、D95、D90、D50 to D2, the effect is not
obvious in 3DCRT. The differences of dose-volume pointsong the TPS calculations and the MC simulations and
PBC algorithm evaluation
Meas PBC MUs DiffPBC-Meas MC DiffMC-Meas
194.6 200.5 240 3.0% 195.8 0.6%
nte Carlo; Meas =measurement.
Figure 3 (See legend on next page.)
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Figure 3 Comparison of the dose distributions and DVHs of a lung cancer patient? s four treatment plans; on the left are the dose
distributions, the thin line represents the TPS, the thick line represents MC, on the right are the DVHs corresponding to the left,
dotted line represents TPS and solid line represents MC. a) IMRT plans calculated using CCC and MC recalculation, b) 3DCRT plans calculated
using CCC and MC recalculation c) IMRT plans calculated using PBC and MC recalculation d) 3DCRT plans calculated using PBC and
MC recalculation.
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become smaller gradually from D98、D95、D90、D50 to
D2 for IMRT plans too, the effect is less pronounced for
3DCRT. In general, the differences of dose-volume points
for GTV between PBC and MC are larger than that of
CCC and MC.
Table 3 shows the results of the statistical analysis for
the ipsilateral lung. As shown in the table, the CCC algo-
rithm overestimated the dose for the entire lung, overesti-
mated V5, V10, and V20 by 1.1%, 0.97%, and 0.95% for the
3DCRT plans, respectively, and overestimated V5, V10, and
V20 by 1.95%, 1.6%, and 1.72% for the IMRT plans, respect-
ively. The PBC overestimated V20 by 1.49% but underesti-
mated V5 by 2.7% for 3DCRT, the difference in V10 was not
statistically significant. The PBC overestimated the average
V10 and V20 by1.44% and1.78%, respectively for the IMRT
plans but underestimated the average V5 by 1.34%.Discussion
In this study, we used 24 patients to investigate the ef-
fects of the dose calculation accuracy on plan evaluation
for lung cancer treatments. Both based on the statistical
analysis and the evaluation of all individual patient
cases, it is clear that large discrepancies occur between
the different dose calculation algorithms. Therefore,
substantial deviations will occur when an insufficiently
accurate dose computation algorithm is selected. For
lung cancer treatment planning, it is very important to
consider the differences in tissue density during dose
calculation and to accurately model secondary electronTable 2 Results of the statistical analysis for GTV and PTV, fo
of the paired t test are reported
Dmean (%) p D98 (%) p D
3DCRT CCC vs. MC GTV 0.62 0.16 0.68 0.18 0
PTV 0.42 0.32 −0.39 0.40 −
PBC vs. MC GTV 5.95 0.00 7.57 0.00 7
PTV 7.96 0.00 12.51 0.00 1
IMRT CCC vs. MC GTV 3.43 0.00 5.36 0.00 5
PTV 3.05 0.00 3.37 0.00 3
PBC vs. MC GTV 7.81 0.00 12.84 0.00 1
PTV 10.23 0.00 20.76 0.00 1
Note: GTV = gross tumour volume; PTV = planning target volume; MC =Monte Carlotransport [13,22]. If the lower attenuation of photon
beams within lung tissue is not considered, the dose to
the tissues downstream will be underestimated. Further-
more, as the electron path length within the lung
extends to several centimetres, the beam penumbra
widens, larger volumes of the lung are exposed to sig-
nificant doses and the dose near the beam edge de-
creases [23,24]. Additionally, an unbalance between the
number of produced and absorbed electrons arses near
the interface between the low and high density tissues
causes the dosage to build up [25-27]. If the electronic
disequilibrium effect is not considered, it will again
cause an underestimation of the dose to the lung. These
effects are expected to become more pronounced for
smaller field sizes, higher photon energies, and decreased
lung densities [25,28,29].
The CCC is a superposition method based on a point
kernel convolution with a fixed number of different direc-
tions along which the energy is transported from each grid
point in the patient [17]. It employs three-dimensional
(3D) density scaling of their kernels for inhomogeneity
[30], whereas PBC applies only a one-dimensional convo-
lution along fan lines [31]. The inhomogeneity correction
is performed by an Equivalent Path Length correction
(EPL) (i.e., using effective depths) [17].
Regarding dose reporting, PBC algorithms calculated
the dose-to-water (Dw) while the MC and CCC results
reported herein were dose-to-medium (Dm). In lung tis-
sue and soft tissue, the differences between Dw and Dm
are only approximately 1% [8,32-34]. A direct compari-
son of the two dose calculation algorithms (PBC andr the mean dose and every dose-volume point, the results
95 (%) p D90 (%) p D50 (%) p D2 (%) p
.86 0.08 0.91 0.62 0.79 0.08 0.019 0.97
0.25 0.61 0.05 0.91 0.53 0.22 0.013 0.98
.28 0.00 6.95 0.00 5.76 0.00 4.63 0.00
1.18 0.00 10.04 0.00 7.61 0.00 5.85 0.00
.06 0.00 4.77 0.00 3.51 0.00 1.15 0.02
.39 0.00 3.50 0.00 3.27 0.03 2.16 0.03
1.49 0.00 10.50 0.00 7.44 0.00 5.04 0.00
8.07 0.00 15.9 0.00 9.4 0.00 5.41 0.00
; CCC vs. MC means (DCCC-DMC)/DMC; PBC vs. MC means (DPBC-DMC)/DMC.
Table 3 Results of the statistical analysis for ipsilateral
lung, results of the paired t test are reported
V5 Gy p V10 Gy p V20 Gy p
3DCRT CCC vs. MC 1.10 0.01 0.97 0.00 0.95 0.00
PBC vs. MC −2.70 0.00 0.17 0.47 1.49 0.00
IMRT CCC vs. MC 1.95 0.00 1.6 0.00 1.72 0.00
PBC vs. MC −1.34 0.00 1.44 0.00 1.78 0.00
Note: GTV = gross tumour volume; PTV = planning target volume; MC =Monte
Carlo; CCC vs. MC means VCCC-VMC; PBC vs. MC means VPBC-VMC.
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error into Dm vs. Dw.
Differences have been found when comparing PBC
and CCC with MC algorithms for lung cancer treat-
ment. The results of this study show that the dose pre-
diction of CCC is closer to MC than that of PBC. Our
previous study [25] and other previous studies [6-9,18]
all discovered that the quantification of the difference
between CCC and MC, PBC and MC depend on beam
energy, lung density, target volume, target position and
geometry.
In previous studies Dobler et al. presented the results
of a comparison between PB, CC, XVMC, and film
measurement in one phantom case and indicated that
there was a deviation of approximately 8% between CC
and measurement/XVMC for beam energy of 6MV [7].
Huixiao Chen et al. compared the distributions of PB,
XVMC, and film measurement for typical plan applied
to inhomogeneous anthropomorphic phantom, and dis-
covered that the deviation between PB and film meas-
urement was up to 15%. They also compared the dose
calculation between PB and XVMC for 35 clinical cases,
and revealed that the deviation of mean dose for PTV
and GTV between PB and XVMC was approximatelya)
























Figure 4 Mean dose differences of GTV between a) CCC and MC b) PB7% and 4%, respectively [31]. Stephen F. Kry et al. retro-
spectively analyzed the results of 304 irradiations of the
Radiological Physics Center (RPC) thorax phantom at
221 different institutions as part of credentialing for
RTOG clinical trials. The results revealed that: PB algo-
rithm overestimated the dose delivered to the centre of
the target by 4.9% on average; convolution/superposition
(CS) algorithms also showed a systematic overestimation
of the dose to the centre of the target by 3.7% on aver-
age; in contrast, the MC algorithm dose calculations
agreed with measurement within 0.6% on average [35].
For the most part, these studies are consistent with our
results.
In general, the MC calculation is considered more reli-
able than the SC calculation. However, it should be noted
that the MC calculation has an intrinsic deviation arising
from statistical accuracy. This uncertainty is larger in low-
dose regions.
A discrepancy between PBC and MC, CCC and MC
maybe involve the uncertainty arising from both the beam
modeling and CT-to-density curves used in MC calcula-
tion. MC uses the physical density as the user input,
whereas Oncentra Masterplan uses the electron density.
Conclusions
We compared the Monte Carlo algorithm with two
commercial treatment planning algorithms (CCC and
PBC) for 24 lung cancer patients. The CCC algorithm
overestimates the mean dose to the tumour by ap-
proximately 3% in the IMRT but is very close to the
MC simulation in 3DCRT. The PBC overestimates the
dose to the tumour in both 3DCRT and IMRT. There-
fore, it is recommended that the treatment plan for
lung cancer should be calculated using an advanced
dose calculation algorithm other than the PBC algo-
rithm. In IMRT, we should be pay more attention tob)


























C and MC for all individual patients.
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misation parameters, if the minimum segment width is
too small, it will probably bring lager uncertainty. To
enhance the calculation accuracy, when commission-
ing a treatment planning system, one should attach
great importance to the similarity between the calcula-
tions and the measurements for small fields, rather
than focusing on large fields [6]. In our study, the
Monte Carlo dose calculation results were quite con-
sistent with the measurements. Therefore, if the Monte
Carlo code had to be benchmarked before clinical use,
the MC can provide a very good tool for benchmarking
the performance of other dose calculation algorithms
within patients (where measurements are difficult or
even impossible) [13].
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